Quantcast

Latest diabetic peripheral neuropathy Stories

2014-05-22 23:04:58

RnRMarketResearch.com adds “Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2014” to its store. Order a purchase copy @ http://www.rnrmarketresearch.com/contacts/purchase?rname=179159. Dallas, Texas (PRWEB) May 22, 2014 This report provides comprehensive information on the therapeutic development for Diabetic Peripheral Neuropathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of...

2013-05-16 23:04:04

A company known for its natural approach to treating various ailments, Neuracel has launched its latest product, called the Ultimate Neuropathy Support System at http://www.neuracel.com. With this product, the company hopes to provide a treatment for peripheral neuropathy that is not only effective, but also natural. Boise, ID (PRWEB) May 16, 2013 A disorder of the nerves, Diabetic Peripheral Neuropathy is a disease that has an adverse affect on the health of millions of people worldwide....

2011-06-16 07:00:00

LA JOLLA, Calif., June 16, 2011 /PRNewswire/ -- Cebix Incorporated announced today it is advancing the development of modified C-peptide for the treatment of complications of diabetes. The biopharmaceutical company has initiated a Phase 1b clinical trial to evaluate Ersatta(TM), its proprietary long-acting form of C-peptide, in patients with type 1 diabetes who, because of their disease, lack this endogenous peptide. Following the successful completion of this study, the company is...

2009-10-27 14:36:36

HealthCore study shows Metanx also reduces health plan costs Diabetic patients diagnosed with peripheral neuropathy had lower medical costs and reduced use of anticonvulsant medications when treated with a folate-enriched prescription medical food, according to data presented today at the International Society for Pharmacoeconomics and Outcomes Research 12th Annual European Congress. The results of the HealthCore, Inc. study, funded by Pamlab, L.L.C., which manufactures the medical food...

2009-10-27 01:00:00

PARIS, Oct. 27 /PRNewswire/ -- Diabetic patients diagnosed with peripheral neuropathy had lower medical costs and reduced use of anticonvulsant medications when treated with a folate-enriched prescription medical food, according to data presented today at the International Society for Pharmacoeconomics and Outcomes Research 12th Annual European Congress. The results of the HealthCore, Inc. study, funded by Pamlab, L.L.C., which manufactures the medical food Metanx®,...

2009-01-14 06:55:29

Scientist cautions that activities should be supervised closely by a medical professional More than 20 million Americans are living with diabetes, and that number is expected to increase by more than 5 million by 2010. One complication related to diabetes, Diabetic Peripheral Neuropathy, (DM+PN), can cause individuals to develop foot ulcers and, in extreme cases, amputation might be necessary. Previously, doctors and scientists have recommended that individuals with this complication stay off...

2008-11-12 09:00:10

DOYLESTOWN, Pa., Nov. 12 /PRNewswire-FirstCall/ -- Quigley Pharma Inc., a wholly-owned subsidiary of The Quigley Corporation announced today that the last subject in the Phase IIb Study is scheduled to complete treatment on November 25, 2008. This will effectively move the study to the final stage of data collection, evaluation and study conclusions. The Company, after collecting all the patient information from 21 Study centers and conferring with its panel of experts on the data, will...

2007-12-14 09:00:50

Adolor Corporation (Nasdaq: ADLR) announced today the initiation of a third Phase 2a study of ADL5859, a novel Delta opioid agonist in development for the treatment of pain. Study 33CL231 will explore the analgesic efficacy of ADL5859 in treating pain associated with diabetic peripheral neuropathy. Recently, Adolor and Pfizer Inc (NYSE: PFE) entered into a collaboration to develop and commercialize two Delta opioid agonist compounds, including ADL5859, for the treatment of a wide range...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related